Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H19N5 |
| Molecular Weight | 293.3663 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C(N1CCN(CC1)C2=NC=CC=C2)C3=NC4=CC=CC=C4N3
InChI
InChIKey=FRPJGTNLZNXQEX-UHFFFAOYSA-N
InChI=1S/C17H19N5/c1-2-6-15-14(5-1)19-16(20-15)13-21-9-11-22(12-10-21)17-7-3-4-8-18-17/h1-8H,9-13H2,(H,19,20)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. | 2004 Apr 22 |
|
| Discovery of 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole (ABT-724), a dopaminergic agent with a novel mode of action for the potential treatment of erectile dysfunction. | 2004 Jul 15 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4WV2575JWT
Created by
admin on Sat Dec 16 09:44:17 GMT 2023 , Edited by admin on Sat Dec 16 09:44:17 GMT 2023
|
PRIMARY | |||
|
DTXSID001025592
Created by
admin on Sat Dec 16 09:44:17 GMT 2023 , Edited by admin on Sat Dec 16 09:44:17 GMT 2023
|
PRIMARY | |||
|
70006-24-5
Created by
admin on Sat Dec 16 09:44:17 GMT 2023 , Edited by admin on Sat Dec 16 09:44:17 GMT 2023
|
PRIMARY | |||
|
ABT-724
Created by
admin on Sat Dec 16 09:44:17 GMT 2023 , Edited by admin on Sat Dec 16 09:44:17 GMT 2023
|
PRIMARY | |||
|
5025739
Created by
admin on Sat Dec 16 09:44:17 GMT 2023 , Edited by admin on Sat Dec 16 09:44:17 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
